NEW YORK, April 12, 2017 /PRNewswire/ -- Rosen Law Firm, a
global investor rights law firm, reminds purchasers of Galena Biopharma, Inc. securities (NASDAQ: GALE) from August 11, 2014 through January 31, 2017, both dates inclusive (the "Class
Period") of the April 14, 2017 lead plaintiff deadline in the class action first filed by Rosen Law
Firm. This first filed lawsuit seeks to recover damages for Galena investors under the federal securities laws.
To join the Galena class action, go to http://www.rosenlegal.com/cases-1054.html or call Phillip Kim, Esq. or
Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU
RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period Defendants made false and/or misleading statements and/or failed to
disclose that: (1) Galena's sales of Abstral were based on unsustainable sales and marketing practices; (2) such sales and
marketing practices could subject Galena to a criminal investigation; and (3) as a result, Defendants' statements about Galena's
business, operations, and prospects, were false and misleading and/or lacked a reasonable basis. When the true details entered
the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than
April 14, 2017. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-1054.html or to discuss your
rights or interests regarding this class action, please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and
shareholder derivative litigation. Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
kchan@rosenlegal.com
www.rosenlegal.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/gale-april-14-alert-rosen-law-firm-reminds-galena-biopharma-inc-investors-of-important-deadline-in-class-action--gale-300438814.html
SOURCE Rosen Law Firm, P.A.